32- Gouda,M.; Bawazeer, M.; Hegazy, L.; Azab, M.; Elagawany, M.; Rateb, M.; Yaseen, M.; Elgendy, B. Design, Synthesis and Antitumor Activity of Novel Dispiro [oxindole-cyclohexanone]-pyrrolidines. Curr. Pharm. Des., 2021,

31- Elagawany, M.; Maram, L.; Elgendy, B. Novel Synthesis of Benzotriazolyl Alkyl Esters: An Unprecedented CH₂ Insertion. RSC Adv. 2021, 11, 7564.

30- Ibrahim, T. S.; Hawwas, M. M.; Taher, E. S.; Alhakamy, N. A.; Alfaleh, M. A.; Elagawany, M.; Elgendy, B.; Zayed, G. M.; Mohamed, M. F. A.; Abdel-Samii, Z. K.; Elshaier, Y. A. M. M. Design and synthesis of novel pyrazolo[3,4-d]pyrimidin-4-one bearing quinoline scaffold as potent dual PDE5 inhibitors and apoptotic inducers for cancer therapy. Bioorg. Chem., 2020, 105, 104352.

29-Shahien, M.; Elagawany, M.; Sitaula, S.; Goher, S. S.; Burris, S. L.; Sanders, R.; Avdagic, A.; Billon, C.; Hegazy, L.; Burris, T. P.; Elgendy, B. Modulation of Estrogen-Related Receptors Subtype Selectivity: Conversion of an ERRβ/γ Selective Agonist to ERRα/β/γ Pan Agonists. Bioorg. Chem. 2020, 104079.

28-Elzahhar, P.A.; Abd El Wahab, S.M.; Elagawany, M.; Daabees, H.; Belal, A.S.F.; EL-Yazbi, A.F.; Eid, A.H.; Alaaeddine, R.; Hegazy, R.R.; Allam, R.M.; Helmy, M. W.; Elgendy, B.; Angeli, A.; El-Hawash, S. A.; Supuran, C. T. Expanding the anticancer potential of 1,2,3-triazoles via simultaneously targeting Cyclooxygenase-2, 15-lipoxygenase and tumor-associated carbonic anhydrases Eur. J. Med. Chem. 2020, 200, 112439.

27-Ibrahim, T.S.; Seliem, I.A.; Panda, S.S.; Al-Mahmoudy, A.M.M.; Abdel-Samii, Z.K.M.; Alhakamy, N.A.; Asfour, H.Z.; Elagawany, M. An Efficient Greener Approach for N-acylation of Amines in Water Using Benzotriazole Chemistry Molecules 2020, 25, 2501.

26-Ibrahim, T. S.; Bokhtia, R. M.; AL-Mahmoudy, A. M. M.; Taher, E. S.; AlAwadh, M. A.; Elagawany, M.; Abdel-Aal, E. H.; Panda, S.; Gouda, A. M.; Asfour, H. Z.; Alhakamy, N. A.; Youssif, B.G. M. Design, Synthesis and Biological Evaluation of Novel 5-((Substituted Quinolin-3-Yl/1-Naphthyl) Methylene)-3-Substituted Imidazolidin-2,4-Dione as HIV-1 Fusion Inhibitors Bioorg. Chem. 2020, 99, 103782.

25-Saaed, W.; Elagawany, M.; Azab, M. M.; Amin, A. S.; Rath, N. P.; Hegazy, L.; Elgendy, B. Catalyst-and Organic Solvent-Free Synthesis, Structural, and Theoretical Studies of 1-Arylidenamino-2,4-Disubstituted-2-Imidazoline-5-Ones Results Chem.2020, 2, 100042.

24-Panda, S.S.; Girgis, A.S.; Mishra, B.B.; Elagawany, M.; Devarapalli, V.; Littlefield, W.F.; Samir, A.; Fayad, W.; Fawzy, N.G.; Srour, A.M.; Bokhtia, R.M. Synthesis, computational studies, antimycobacterial and antibacterial properties of pyrazinoic acid–isoniazid hybrid conjugates RSC Adv., 2019, 9, 20450.

23-Elagawany, M.; Hegazy, L.; Elgendy, B. Catalyst- and organic solvent-free synthesis of thioacids in water Tetrahedron Lett., 2019, 60, 2018.

22-Elagawany, M.; Fared, N. F.; Elgendy, B.; Abdelmomen, E. H.; Abdelwahab, N. S.  Baclofen Impurities: Facile Synthesis and Novel Environmentally Benign Chromatographic Method for their Simultaneous Determination in Baclofen Biomed Chromatogr., 2019, 33, e4579.

21-Ghoneim, M. M.; Afifi, W. M.; Ibrahim, M.; Elagawany, M.; Khayat, M. T.; Aboutaleb, M. H.; Metwaly, A. M. Biological evaluation and molecular docking study of metabolites from Salvadora Persica L. Growing in Egypt Pharmacogn Mag., 2019,15, 232.

20-Goher, S. S.; Griffett, K.; Hegazy, L.: Elagawany, M.; Arief, M. M. H.; Avdagic, A.; Banerjee, S.; Burris, T. B.; Elgendy, B. Development of novel liver X receptor modulators based on a 1, 2, 4-triazole scaffold Bioorg. Med. Chem. 2019,29, 449.

19-Cao, F.; Orth, C.; Donlin, M. J.; Adegboyega, P.: Meyers, M. J.; Murelli, R. P.; Elagawany, M.; Elgendy, B.; Tavis, J. E. Synthesis and Evaluation of Troponoids as a New Class of Antibiotics ACS omega, 2018, 3, 15125.

18-Elagawany, M.; Hegazy, L.; Cao, F.; Donlin, M. J.; Rath, N.; Tavis, J.; Elgendy, B. Identification of 4-isopropyl–thiotropolone as a novel anti-microbial: regioselective synthesis, NMR characterization, and biological evaluation RSC Adv., 2018, 8, 29967.

17-Abdelwahab, N. S.; Fared, N. F.; Elagawany, M.; Abdelmomen, E. H.  Efficient UPLC and CE methods for the simultaneous determination of azelastinehydrochloride and its genotoxic impurity Biomed Chromatogr., 2018, 32, e4346.

16-Panda, S. S.; Asiri, A. M.; Elagawany, M.; Buchanan, D. D.; Torklan, B.; Bathala, K.; Thomas, S. J.; Capito, J. E.; Arshad, M. N.; Al-Romaizan, A. N. Efficient Synthesis of Pyrazinoic Acid Hybrid Conjugates Synopen, 2017, 1, 50.

15-Elagawany M.; Ibrahim, M. A.; Ibrahim, T. S.; EL-Mahmoudy, A. M. M.; Moawad, A.; Ghoneim, M. M.; Radwan, M. M.; Panda S. S.  Synthesis and Anticancer Studies of Novel N-Benzyl pyridazinone Derivatives Lett. Drug Des. Discovery, 2017, 14, 1008.

14-Abdelwahab, N. S.; Fared, N. F.; Elagawany, M.; Abdelmomen, E. H.  Different Spectrophotometric and Chromatographic Methods for Determination of Mepivacaine and Its Toxic Impurity J. AOAC Int., 2017, 100, 1392.

13-Elagawany M.; Ibrahim, M. A.; Panda S. S.  One-Pot Synthesis of Bi- and Tricyclic Heterocyclic Compounds using Benzotriazole Chemistry Tetrahedron Lett., 2016, 44, 4910.

12-Elagawany M.; Ibrahim, M. A. An improved route for the synthesis of Rolloamide B Tetrahedron Lett., 2016, 34, 3837.

11-Ibrahim, T. S.; EL-Mahmoudy, A. M. M.; Elagawany M.; Ibrahim, M. A.; Panda S. S. Synthesis and Antiviral Bioassay of New Diphenyl ether Based Compounds Chem. Biol. Drug Des., 2016, 88, 511.

10-Ibrahim, M. A.; Elagawany M.; Ibrahim, T. S. Green and catalyst-free synthesis of olsalazine analogs Green Chem. Lett. Rev., 2016, 9, 91.

9-    Ibrahim, M. A.; Panda S. S.; Oliferenko A. A.; Oliferenko P. V.; Girgis A. S.; Elagawany M.; Küçükbay F. Z.; Panda C. S.; Pillai G. G.; Samir A.; Tämm K.; Hall C. D.; Katritzky A. R. Macrocyclic peptidomimetics with antimicrobial activity: synthesis, bioassay, and molecularmodeling studies Org. Biomol. Chem., 2015, 13, 9492.

8-    Ibrahim, M. A.; Elmenoufy, A. H.; Elagawany, M.; Ghoneim, M. M.; Moawad, A. Pyridopyridazine”: A Versatile Nucleus in Pharmaceutical Field. Journal of Biosciences and Medicines, 2015, 3, 59.

7-    Panda, S. S.; Elagawany, M.; Marwani, H. M.; Çalışkan, E.: El Khatib, M.; Oliferenko, A.; Alamry, K. A.; Katritzky, A. R. Chemical ligation from O-acyl isopeptides via 8- and 11-membered cyclic transition states, ARKIVOC2014,(iv) 91-106

6-    Elagawany, M.; Schmitt, M.; Ghiaty, A.; El-Etrawy, A. Sh.; Ibrahim, M. A.; Bihel, F.; Sbardelotto, A. B.; Pessoa, C.; Nguyen, T. L.; Hamel, E; Bourguignon, J. J.Synthesis and Antiproliferative Effects of 5,6-Disubstituted Pyridazin-3(2H)-ones Designed as Conformationally Constrained Combretastatin A-4 Analogues Anti-Cancer Agents in Medicinal Chemistry 2013, 13, 1133.

5-    El Khatib,  M.;  Elagawany, M.;  Çalışkan, E.; Davis, E. F.;  Faidallah, H.M.; El-feky, S. A.; Katritzky, A. R. Total Synthesis of Cyclic Heptapeptide Rolloamide B Chem. Commun.,2013,10, 4836.

4-    Elagawany, M.;Ibrahim, M. A.; Ahmed, H. E. A.; El-Etrawy, A. Sh.; Ghiaty, A.; Abdel-Samii, Z. K.; El-Feky, S. A.; Bajorath, J. Design, Synthesis, and Molecular Modelling of Pyridazinone and Phthalazinone Derivatives as Protein Kinases Inhibitor Bioorg. Med. Chem. 2013,23, 2007.

3-    Ibrahim, M. A.; Blaise, E.; Lozach, O.; Szalata, C.; Schmitt, M.; El-Etrawy, A. S.; Elagawany, M.; El-Feky, S. A.; Abdel-Samii, Z. K.; Meijer, L.; Bourguignon, J. J.; Bihel, F. Palladium-catalyzed synthesis of substituted pyrido[2,3-d]pyridazines at positions 5 and 8 Synthesis 2012, 44, 3216.

2-    El Khatib, M.;Elagawany, M.; Jabeen, F.; Todadze, E.; Bol’shakov, O.; Oliferenko, A.; Khelashvili, L.; Katritzky, A. R. Traceless Chemical Ligations at Ser- sites through O- to N- Acyl Shifts Org. Biomol. Chem. 2012, 10, 4836.

1-    El Khatib, M.; Elagawany, M.; Todadze, E.; Khelashvili, L.; El-Feky, S. A.; Katritzky, A. R. Microwave Assisted Synthesis of Regiospecific Pseudohalohydrin esters Synlett 2012, 23, 1384.